Aster Capital Management’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Aster Capital Management's CGEM Position: Q3 2026 in Review
Aster Capital Management opened a new position in Cullinan Therapeutics (CGEM) in Q3 2026: 304 shares worth $4.67K. The stake represents ﹤0.01% of the portfolio and ranks #851 among its holdings.
182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Aster Capital Management held 304 shares of Cullinan Therapeutics worth $4.67K as of Q3 2026.
- Cullinan Therapeutics was a new Aster Capital Management position in Q3 2026.
- Cullinan Therapeutics made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #851 holding.
- 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.